- Vant
VantAI launches Neo-1, the first AI model to rewire molecular interactions by unifying structure prediction and generation for therapeutic design
- VantAI
VantAI, a company focused on generative AI-enabled drug discovery, and Bristol Myers Squibb, a leading pharmaceutical company, have entered into a strategic collaboration to discover new molecular glues for therapeutic targets of interest
- www. vant. ai
VantAI was started with a grand vision: making protein interactions programmable The current approach to designing artificial proteins as therapies is, in a sense, reinventing the wheel
- Our Team - Vant
HEAD OF FINANCE AND ACCOUNTINGAdriana Altomonte
- Apply Today - Vant
Utilize your skills to help us tackle some of the most complex and meaningful scientific challenges on the planet
- Get in Touch - Vant
116 East 16th Street, 12th Floor New York, NY 10003 hi@vant ai
- www. vant. ai
VantAI, a leader in generative AI and drug discovery, today announced the appointment of John Cuozzo, PhD as SVP, Head of Drug Discovery Cuozzo is an experienced scientific leader with a strong track record of building novel discovery platforms and leading successful drug discovery programs
- Command line interface — peppr
Command line interface # One way to use peppr to compute a single metric or run entire model evaluations is via the command line interface In peppr we call each input structure, which consists of a reference and one or more poses, a system This tutorial uses proteolysis targeting chimera (PROTAC) complexes predicted from the PLINDER dataset as systems to be evaluated (download here) and
|